• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于评估夏科氏神经关节病影响的放射学严重程度评分:一项观察性研究。

A radiological severity scale to measure the impact of Charcot's Neuroarthropathy: an observational study.

机构信息

Monash Health, Department of Podiatry, David Street, Dandenong, VIC, 3175, Australia.

Monash Health, Monash Imaging, David Street, Dandenong, VIC, 3175, Australia.

出版信息

J Foot Ankle Res. 2020 Feb 11;13(1):7. doi: 10.1186/s13047-020-0375-5.

DOI:10.1186/s13047-020-0375-5
PMID:32046771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7014691/
Abstract

BACKGROUND

Charcot's Neuroarthropathy (Charcot foot) is a debilitating and destructive disorder resulting from neurological changes in the foot. Whilst the majority of cases are painless, as a result of disruption to sensory function, a common outcome is severe deformity that impacts considerably on foot function. The purpose of this study was to develop and validate a radiological severity scale to quantify resultant damage from acute mid foot Charcot's. This in turn can be used to evaluate clinical outcomes related to different degrees of offloading.

METHODS

A four round Delphi process was used to develop five tool items. Level of consensus and agreement was set at 80%. Inter-rater and intra-rater reliability was evaluated using 3 raters and 24 plain x-rays of chronic mid-foot Charcot's. Strength of agreement of individual items and overall scores was calculated using weighted Kappa coefficients (S.E). Cronbach's α was used to determine internal consistency. Floor (> 15% score 0) and ceiling (> 15% score 11) effects were examined at each time point. Spearman's correlation coefficient was used to assess construct validity using Mobility and Usual Activity scores taken from the EQ-5D-5 L.

RESULTS

Twenty two patients participated. The five item severity scale demonstrated a Cronbach's α of 0.91. Intra-rater Kappa coefficients (SE) for total scores ranged from 0.84 (0.20) to 0.86 (0.20). Inter rater coefficients (SE) ranged from 0.72 (0.14) to 0.83 (0.14). Distribution was normal and no floor or ceiling effects were identified.

CONCLUSION/INTERPRETATION: This study suggests it may be possible to quantify resultant damage from mid foot Charcot's. Given the physical and emotional impacts from long periods of complete immobilisation defining a minimum standard would be an important development in the management of Charcot foot.

摘要

背景

夏科氏关节病(夏科足)是一种由足部神经变化引起的使人虚弱和具破坏性的疾病。虽然大多数病例没有疼痛,但由于感觉功能的中断,常见的后果是严重的畸形,这对足部功能有很大的影响。本研究的目的是开发和验证一种放射学严重程度评分标准,以量化急性中足夏科氏病的结果性损伤。这反过来又可以用来评估与不同程度减压相关的临床结果。

方法

采用四轮德尔菲法制定了 5 项工具项目。共识和一致性的水平设定为 80%。采用 3 名评估者和 24 例慢性中足夏科氏病的普通 X 线片评估组内和组间的可靠性。采用加权 Kappa 系数(S.E.)计算各项目和总分的一致性程度。采用 Cronbach's α 确定内部一致性。在每个时间点检查地板(>15%评分为 0)和天花板(>15%评分为 11)效应。采用 EQ-5D-5L 中的移动性和日常活动评分,使用 Spearman 相关系数评估结构效度。

结果

共有 22 例患者参与研究。五项严重程度评分标准的 Cronbach's α 值为 0.91。总分的组内 Kappa 系数(SE)范围为 0.84(0.20)至 0.86(0.20)。组间系数(SE)范围为 0.72(0.14)至 0.83(0.14)。分布正常,未发现地板或天花板效应。

结论/解释:本研究表明,可能可以量化中足夏科氏病的结果性损伤。鉴于长时间完全固定所带来的身体和情感影响,定义一个最低标准可能是夏科氏足管理的一个重要发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efba/7014691/28de719613fc/13047_2020_375_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efba/7014691/acfa4722a5e7/13047_2020_375_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efba/7014691/28de719613fc/13047_2020_375_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efba/7014691/acfa4722a5e7/13047_2020_375_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efba/7014691/28de719613fc/13047_2020_375_Fig2_HTML.jpg

相似文献

1
A radiological severity scale to measure the impact of Charcot's Neuroarthropathy: an observational study.一种用于评估夏科氏神经关节病影响的放射学严重程度评分:一项观察性研究。
J Foot Ankle Res. 2020 Feb 11;13(1):7. doi: 10.1186/s13047-020-0375-5.
2
Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)在糖尿病神经骨关节病中的潜在作用:它能否区分单纯性夏科氏关节病与骨髓炎及软组织感染?
Nucl Med Commun. 2007 Jun;28(6):465-72. doi: 10.1097/MNM.0b013e328174447f.
3
Tibio-calcaneal fusion by retrograde intramedullary nailing in charcot neuroarthropathy.采用逆行髓内钉固定术治疗夏科氏神经关节病的胫跟融合术
Foot (Edinb). 2018 Mar;34:6-10. doi: 10.1016/j.foot.2017.11.003. Epub 2017 Nov 7.
4
Limited joint mobility and plantar fascia function in Charcot's neuroarthropathy.夏科氏神经关节病中的关节活动受限与足底筋膜功能
Diabet Med. 2001 Jul;18(7):558-61. doi: 10.1046/j.1464-5491.2001.00527.x.
5
Clinical features, radiological characteristics and offloading modalities in stage 0 Acute Charcot's neuroarthropathy - A single centre experience from South India.0期急性夏科氏神经关节病的临床特征、放射学特点及减负方式——来自印度南部的单中心经验
Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1081-1085. doi: 10.1016/j.dsx.2019.01.008. Epub 2019 Jan 22.
6
Evaluation and treatment of stage 0 Charcot's neuroarthropathy of the foot and ankle.足踝部0期夏科氏神经关节病的评估与治疗
J Am Podiatr Med Assoc. 2002 Apr;92(4):210-20. doi: 10.7547/87507315-92-4-210.
7
Power spectral analysis of heart rate variability in patients with Charcot's neuroarthropathy.夏科氏神经关节病患者心率变异性的功率谱分析
J Am Podiatr Med Assoc. 2006 Jan-Feb;96(1):1-8. doi: 10.7547/0960001.
8
Evaluation of Young's modulus in Achilles tendons with diabetic neuroarthropathy.糖尿病神经关节病患者跟腱的杨氏模量评估
J Am Podiatr Med Assoc. 2005 May-Jun;95(3):242-6. doi: 10.7547/0950242.
9
Infrared dermal thermometry is highly reliable in the assessment of patients with Charcot neuroarthropathy.红外皮肤测温法在评估夏科氏神经关节病患者方面具有高度可靠性。
J Foot Ankle Res. 2020 Sep 14;13(1):56. doi: 10.1186/s13047-020-00421-z.
10
Pictorial CME. Acute Charcot's foot.
J Indian Med Assoc. 2008 Nov;106(11):751, 754.

引用本文的文献

1
Controversies in the management of active Charcot neuroarthropathy.活跃期夏科特关节病治疗中的争议
Ther Adv Endocrinol Metab. 2023 Apr 17;14:20420188231160406. doi: 10.1177/20420188231160406. eCollection 2023.

本文引用的文献

1
Current concepts of Charcot foot in diabetic patients.糖尿病患者夏科氏足的当前概念。
Foot (Edinb). 2016 Mar;26:7-14. doi: 10.1016/j.foot.2015.11.001. Epub 2015 Nov 25.
2
Classifications in brief: Eichenholtz classification of Charcot arthropathy.简要分类:夏科特关节病的艾兴霍尔茨分类法。
Clin Orthop Relat Res. 2015 Mar;473(3):1168-71. doi: 10.1007/s11999-014-4059-y. Epub 2014 Nov 21.
3
Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review.
制定基于证据的急性夏科氏神经关节病评估、诊断和管理的临床路径:系统评价。
J Foot Ankle Res. 2013 Jul 30;6(1):30. doi: 10.1186/1757-1146-6-30.
4
Etiology, pathophysiology and classifications of the diabetic Charcot foot.糖尿病夏科氏足的病因、病理生理学及分类
Diabet Foot Ankle. 2013 May 21;4. doi: 10.3402/dfa.v4i0.20872. Print 2013.
5
The pathogenesis of Charcot neuroarthropathy: current concepts.夏科特关节病的发病机制:当前概念
Diabet Foot Ankle. 2012;3. doi: 10.3402/dfa.v3i0.12236. Epub 2012 Jan 10.
6
The Charcot foot in diabetes.糖尿病性夏科氏足
Diabetes Care. 2011 Sep;34(9):2123-9. doi: 10.2337/dc11-0844.
7
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).新的 EQ-5D 五维版本(EQ-5D-5L)的制定和初步测试。
Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.
8
Lower-extremity amputation risk after charcot arthropathy and diabetic foot ulcer.夏科氏关节病和糖尿病足溃疡后的下肢截肢风险。
Diabetes Care. 2010 Jan;33(1):98-100. doi: 10.2337/dc09-1497. Epub 2009 Oct 13.
9
Health related quality of life in patients with Charcot arthropathy of the foot and ankle.足踝夏科氏关节病患者的健康相关生活质量
Foot Ankle Surg. 2008;14(1):11-5. doi: 10.1016/j.fas.2007.07.003. Epub 2007 Oct 22.
10
Charcot arthropathy of the foot and ankle: modern concepts and management review.足部和踝关节夏科氏关节病:现代概念与管理综述。
J Diabetes Complications. 2009 Nov-Dec;23(6):409-26. doi: 10.1016/j.jdiacomp.2008.09.004. Epub 2008 Oct 17.